Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
doi: https://doi.org/10.1101/2020.10.27.20220939
Felice L. Bedford
1University of Arizona, Tucson, AZ, USA
Bastian Greshake Tzovaras
2Université de Paris, Paris, France
Posted October 31, 2020.
Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
medRxiv 2020.10.27.20220939; doi: https://doi.org/10.1101/2020.10.27.20220939
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2675)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12293)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (683)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3927)
- Nursing (212)
- Nutrition (584)
- Oncology (2065)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)